Vimarsana
Biggest News Aggregation in the World

Page 38 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

Denmark to boost healthcare with an extra $739 mln per year - Vimarsana News

Denmark to boost healthcare with an extra $739 mln per year

Denmark will use stronger-than-expected economic growth to boost its healthcare system with an extra 5 billion Danish crowns ($739 million) per year, the country's Prime Minister Mette Frederiksen said on Tuesday.

Namibia declares outbreak of Crimean-Congo fever after patient dies - Vimarsana News

Namibia declares outbreak of Crimean-Congo fever after patient dies

Namibia has declared an outbreak of Crimean-Congo haemorrhagic fever (CCHF) after one person died of the disease in the capital Windhoek, the government said on Tuesday.

Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara - Vimarsana News

Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara

Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.

Purdue Pharma to sell consumer business for $397 mln - Vimarsana News

Purdue Pharma to sell consumer business for $397 mln

Bankrupt Purdue Pharma received a U.S. judge's permission on Tuesday to sell its consumer health business for $397 million to a subsidiary of Arcadia Consumer Healthcare.

Lessons from TSCA Enforcement Discretion for the Nuclear Industry - Vimarsana News

Lessons from TSCA Enforcement Discretion for the Nuclear Industry

The EPA granted enforcement discretion to the nuclear industry to resume using wire and cable intended for use in nuclear power facilities that contained flame retardant banned under Toxic Substances Control Act. Heightened vigilance for TSCA developments is now critical.